Alerts will be sent to your verified email
Verify Email
GUJTHEM
|
Guj. Themis Biosyn
|
Concord Biotech
|
Medicamen Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
34.65 % | 19.73 % | 6.92 % |
|
5yr average Equity Multiplier
|
1.29 | 1.21 | 1.44 |
|
5yr Average Asset Turnover Ratio
|
0.74 | 0.54 | 0.55 |
|
5yr Avg Net Profit Margin
|
35.51 % | 30.4 % | 8.69 % |
|
Price to Book
|
18.81 | 9.36 | 1.92 |
|
P/E
|
104.78 | 47.63 | 43.09 |
|
5yr Avg Cash Conversion Cycle
|
-112.39 Days | 76.63 Days | 49.75 Days |
|
Inventory Days
|
22.82 Days | 79.03 Days | 84.58 Days |
|
Days Receivable
|
70.51 Days | 132.49 Days | 139.4 Days |
|
Days Payable
|
130.88 Days | 157.9 Days | 264.75 Days |
|
5yr Average Interest Coverage Ratio
|
216.76 | 195.92 | 7.03 |
|
5yr Avg ROCE
|
45.66 % | 25.76 % | 10.34 % |
|
5yr Avg Operating Profit Margin
|
47.34 % | 43.43 % | 15.51 % |
|
5 yr average Debt to Equity
|
0.03 | 0.03 | 0.15 |
|
5yr CAGR Net Profit
|
10.07 % | 9.62 % | -11.57 % |
|
5yr Average Return on Assets
|
26.69 % | 16.36 % | 4.73 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.86 % | 44.08 % | 40.46 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-4.13 % | 0.0 | -3.14 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
1.14 % | -0.9 % | 0.0 |
|
Guj. Themis Biosyn
|
Concord Biotech
|
Medicamen Biotech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|